PMI-Hosted Poster Session Orlando

      Nov 11, 2014 - Nov 11, 2014.
      Hyatt Regency Grand Cypress Orlando, 1 Grand Cypress Boulevard, Orlando FL 32836, USA
      Date
      Nov 11, 2014 - Nov 11, 2014
      Location
      Hyatt Regency Grand Cypress Orlando, 1 Grand Cypress Boulevard, Orlando FL 32836, USA
      PMI is currently assessing the risk reduction potential of a portfolio of candidate reduced risk products that we are developing. This PMI-hosted poster session will be an opportunity to hear about the systems toxicology-based approaches PMI is using to assess these new products and to allow you to share your views on our research. Presentations Application of Systems Pharmacology to Identify Exposure Response Markers in Peripheral Blood After Switching to a Candidate Modified Risk Tobacco Product: the Tobacco Heating System 2.1 (THS 2.1) A meta-analysis of human organotypic respiratory cultures exposed to whole cigarette smoke Comparison of the biological impact of cigarette smoke and a prototypic modified risk tobacco product on human versus rat primary normal bronchial epithelial cells Effects of Cigarette Smoke Exposure on the Insulin Resistance-Related Metabolic Changes in the High Fat Diet-fed ApoE Knock-Out Mice High Content Screening analysis of the Biological Impact of Harmful / Potentially Harmful Constituents of Tobacco Smoke Modeling of flow and evolving aerosol particles dynamics for computing local deposition in air-liquid interface experiments A prototypic modified risk tobacco product exhibits reduced effects on chemotaxis and transendothelial migration of monocytes compared with a reference cigarette